Delivery Order SPE2DV17D1047-SPE2DV24F0AKC
Award Date 4/12/24
Potential Completion Date 5/3/24
Potential Value $3.8K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Waukegan, IL 60085, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc., for "Kit IMTST QVUE+ URN 1 STP HCG SER 30 TST" with a potential value of $1,057.20. This contract is part of the larger DLA single-award Indefinite Delivery Contract (IDC) vehicle SPE2DV, which allows DLA to procure up to $5 million worth of medical and pharmaceutical products from Cardinal Health 200 to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order in the amount of $1,246.48 to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of "KIT IMTST QVUE+ 1 STP HCG CMB SER URN 90", which appears to be a medical/diagnostic kit. The contract has a completion date of December 27, 2022 and was awarded on December 23, 2022. No set-aside designation was used. Cardinal Health 200 holds a single-award Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Cardinal Health 200, LLC, a subsidiary of the medical products and services company Cardinal Health, Inc. The contract is for the supply of a medical product described as "KIT IMTST QVUE+ URN 1 STP HCG SER 30 TST" with a potential value of $1,048.40 and a completion date of March 8, 2023. This contract is issued under the single-award Indefinite Delivery Contract SPE2DV held by Cardinal Health...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order worth $1,048.40 to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of "KIT IMTST QVUE+ URN 1 STP HCG SER 30 TST" medical supplies. This Delivery Order is part of Cardinal Health 200's single-award Indefinite Delivery Contract (IDC) SPE2DV with DLA, which allows the agency to procure up to $5 million worth of medical and pharmaceutical products through August 2027. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order valued at $3,868.79 to Cardinal Health 200, LLC, a subsidiary of the major medical products and services company Cardinal Health, Inc. The delivery order is for an "IMTST QVUE+ URN 1 STP HCG SER 30 TST" kit, with a period of performance through July 13, 2023. This order is placed against Cardinal Health 200's single-award Indefinite Delivery Contract SPE2DV with DLA, which allows the agency to procure...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, SPE2DV17D1047|SPE2DV24F9WP4, to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The $1,533.70 contract is for the supply of KIT IMTST QVUE+ 1 STP HCG CMB SER URN 90, a medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cardinal Health 200, LLC with DLA, contract number SPE2DV, which has a ceiling value of up to approximately $5 million and...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,106.65 to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the procurement of a KIT IMTST QVUE 1 STP HCG CMB SER URN 50, which appears to be a medical diagnostic kit. The contract has a completion date of September 17, 2024 and is a firm fixed-price delivery order contract. Cardinal Health 200, LLC is a major supplier of medical and pharmaceutical products to the U.S. federal...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract (SPE2DM20D7004|SPE2DM24FRFHY) valued at $1,860.00 to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of a KIT IMTST QVUE+ URN 1 STP HCG SER 30 TST medical product. This delivery order is placed against an existing Indefinite Delivery Contract (IDC) held by Cardinal Health 200, LLC with DLA, valued at up to $4,999,999 and effective through August 2027. The...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The $1,457.78 contract is for the provision of a medical kit, specifically "KIT IMTST QVUE+ URN 1 STP HCG SER 30 TST". The contract has an anticipated completion date of August 23, 2023 and does not include any set-aside designation. Cardinal Health 200 holds a single-award Indefinite Delivery Contract (IDC) with DLA, which allows...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract is a delivery order with a firm fixed price of $1,137.86 and an ultimate completion date of April 17, 2025. The contract is for a "KIT IMTST QVUE+ URN 1 STP HCG SER 30 TST", which appears to be a medical testing kit. The contract was not set aside for any specific business type. Cardinal Health 200, LLC is the prime contractor and...
- SPE2DV17D1047Indefinite Delivery Contract
- SPE2DV17D1047-SPE2DV24F0AKCDelivery Order
The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a Firm Fixed Price Delivery Order contract, worth up to $3,788.64, to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract, identified as SPE2DV17D1047|SPE2DV24F0AKC, is for the provision of medical supplies, specifically "KIT IMTST QVUE+ URN 1 STP HCG SER 30 TST". This contract is a task order under a larger Indefinite Delivery Contract (IDC) held by Cardinal Health 200, LLC with DLA, valued at up to $5 million, which allows for the rapid procurement of medical and pharmaceutical products. The contract does not have a set-aside designation and the period of performance runs through May 3, 2024.
Generated 7/12/24, 10:14 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 4/12/24 |